Cuts in HIV prevention and access grants by the Trump administration may reverse progress in eliminating the epidemic. Dozens of research projects, including those on improving access to drugs like PrEP, have been terminated, leaving scientists scrambling and risking a resurgence of HIV infections in the US.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay